Related references
Note: Only part of the references are listed.A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing's Disease
Valentina Guarnotta et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Editorial: Health-Related Complications of Acromegaly
Marek Bolanowski et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
National acromegaly registries
Luigi Maione et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
GH replacement titrated to serum IGF-1 does not reduce concentrations of myostatin in blood or skeletal muscle
Ryan G. Paul et al.
GROWTH HORMONE & IGF RESEARCH (2019)
Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis
Pierre Delanaye et al.
JOURNAL OF RENAL NUTRITION (2019)
Metformin-induced autophagy and irisin improves INS-1 cell function and survival in high-glucose environment via AMPK/SIRT1/PGC-1α signal pathway
Qingxue Li et al.
FOOD SCIENCE & NUTRITION (2019)
Irisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway
Xiao Ye et al.
PEPTIDES (2019)
Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly
Mehmet Calan et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
The Beige Adipocyte as a Therapy for Metabolic Diseases
Fernando Lizcano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study
Lizhi Tang et al.
BMC ENDOCRINE DISORDERS (2019)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Irisin Ameliorates Glucolipotoxicity-Associated -Cell Dysfunction and Apoptosis via AMPK Signaling and Anti-Inflammatory Actions
Dan Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
CARDIOVASCULAR COMPLICATIONS OF ACROMEGALY
L. Mizera et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2018)
Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study
Jae Seung Chang et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2017)
Balance Control and Peripheral Muscle Function in Aging: A Comparison Between Individuals with Acromegaly and Healthy Subjects
Telassin Silva Homem et al.
JOURNAL OF AGING AND PHYSICAL ACTIVITY (2017)
Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells
Shiwei Liu et al.
PLOS ONE (2017)
Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
Elena Dozio et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Increased Risk of Persistent Glucose Disorders After Control of Acromegaly
Claire Rochette et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic β-Cell Survival and Insulin Secretion
Annalisa Natalicchio et al.
DIABETES (2017)
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells
M. Hjorth et al.
ACTA PHYSIOLOGICA (2016)
Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues
J. Dong et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway
C. Xin et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency
Viral Chikani et al.
CLINICAL ENDOCRINOLOGY (2016)
Parameters of knee isokinetic dynamometry in individuals with acromegaly: Association with growth hormone levels and general fatigue
Evelyn M. Walchan et al.
ISOKINETICS AND EXERCISE SCIENCE (2016)
Circulating Serum Irisin Levels in Obesity and Type 2 Diabetes Mellitus
Amira Shoukry et al.
IUBMB LIFE (2016)
Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis
Shanhu Qiu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The Impact of Adipose Tissue on Insulin Resistance in Acromegaly
Nicoleta Cristina Olarescu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
Stefano Frara et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population
Simon Oelmann et al.
PLOS ONE (2016)
Relationships between serum irisin levels and metabolic parameters in Japanese patients with obesity
Yaeko Fukushima et al.
OBESITY SCIENCE & PRACTICE (2016)
Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase
Sergiy Sukhanov et al.
ATHEROSCLEROSIS (2015)
Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry
Mark P. Jedrychowski et al.
CELL METABOLISM (2015)
A Structural and Functional Acromegaly Classification
Daniel Cuevas-Ramos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
An update on the validity of irisin assays and the link between irisin and hepatic metabolism
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK
Hye Jeong Lee et al.
MOLECULAR ENDOCRINOLOGY (2015)
Irisin - a myth rather than an exercise-inducible myokine
Elke Albrecht et al.
SCIENTIFIC REPORTS (2015)
Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
Mara Moreno et al.
PLOS ONE (2015)
Prevalence of Atherogenic Dyslipidemia in Spanish Hypertensive Patients and Its Relationship With Blood Pressure Control and Silent Organ Damage
Alejandro de la Sierra et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2015)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Action of GH on skeletal muscle function: molecular and metabolic mechanisms
Viral Chikani et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Serum irisin levels and thyroid function-Newly discovered association
Marek Ruchala et al.
PEPTIDES (2014)
IGF-1 induces IP3-dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation
Juan A. Valdes et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Kyung Hee Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Aerobic Exercise plus Weight Loss Decreases Skeletal Muscle Myostatin Expression and Improves Insulin Sensitivity in Older Adults
A. S. Ryan et al.
OBESITY (2013)
Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo
Ioanna Gouni-Berthold et al.
PLOS ONE (2013)
Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment
Daphne T. Adelman et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2013)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Plasma and Muscle Myostatin in Relation to Type 2 Diabetes
Claus Brandt et al.
PLOS ONE (2012)
Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway
C. Zhang et al.
DIABETOLOGIA (2011)
Restrictive extraocular myopathy: A presenting feature of acromegaly
Steven Heireman et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2011)
Myostatin Decreases with Aerobic Exercise and Associates with Insulin Resistance
Dustin S. Hittel et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2010)
The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
Swapnil N. Rajpathak et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
The decrease in mature myostatin protein in male skeletal muscle is developmentally regulated by growth hormone
Jenny M. Oldham et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity
Tingqing Guo et al.
PLOS ONE (2009)
Gene Expression in Skeletal Muscle Biopsies from People with Type 2 Diabetes and Relatives: Differential Regulation of Insulin Signaling Pathways
Jane Palsgaard et al.
PLOS ONE (2009)
High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease
Protasio Lemos da Luz et al.
CLINICS (2008)
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly
Pamela U. Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
BQ Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo
H Kim et al.
ENDOCRINOLOGY (2005)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Changes in muscle myostatin expression in obese subjects after weight loss.
G Milan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Growth hormone, acromegaly, and heart failure: an intricate triangulation
L Sacca et al.
CLINICAL ENDOCRINOLOGY (2003)
Myostatin is a skeletal muscle target of growth hormone anabolic action
W Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone
TK Hansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men
TJ Marcell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Share Paper
